LOVE Share Price Performance
CA$0
-1.78 (-100.00%)
Price CA$0
Fair ValueCA$4.00
Share Pricen/a
New Narrative • Aug 01
Cannara Biotech Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 25 Fair Values set on narratives written by author
LOVE Community Narratives
AN
Fair Value
·Fair Value CA$4 50.0% undervalued intrinsic discount
Expanded Valleyfield Capacity And Blue River Partnership Will Anchor Long-Term Cannabis Upside
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AN
Fair Value
·Fair Value CA$3.19 37.3% undervalued intrinsic discount
Expanded Capacity And EU Export Optionality Will Support Long Term Premium Cannabis Demand
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value
·Fair Value CA$3 33.3% undervalued intrinsic discount
Capacity Expansion And Rising SG&A Will Test Margins Yet Future Exports May Offer Relief
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Expanded Valleyfield Capacity And Blue River Partnership Will Anchor Long-Term Cannabis Upside
Cannara Biotech is expanding its Valleyfield grow site and leaning on a new partnership to bring more distinctive cannabis products to shelves across Canada. The upside hinges on whether demand keeps up and whether overseas medical sales through Curaleaf ramp smoothly, while new capacity and shifting regulations remain key things to watch.Read more
AN
CA$4
50.0% undervalued intrinsic discount
Fair Value
Revenue
25.98% p.a.
Profit Margin
23.51%
Future PE
9.82x
Price in 2029
CA$4.86
Capacity Expansion And Rising SG&A Will Test Margins Yet Future Exports May Offer Relief
Cannara Biotech is ramping up cannabis production and rolling out more vape and pre-roll products, but it’s doing it in a Canadian market that isn’t growing much, which could squeeze profits if sales don’t keep pace. A potential pressure valve is exporting to Europe, yet approvals, timing, and overseas pricing may decide whether that plan actually helps.Read more
AN
CA$3
33.3% undervalued intrinsic discount
Fair Value
Revenue
25.66% p.a.
Profit Margin
19.98%
Future PE
8.73x
Price in 2029
CA$3.64
Expanded Capacity And EU Export Optionality Will Support Long Term Premium Cannabis Demand
Catalysts About Cannara Biotech Cannara Biotech is a vertically integrated Canadian cannabis producer focused on premium branded products at competitive price points. What are the underlying business or industry changes driving this perspective?Read more
AN
CA$3.19
37.3% undervalued intrinsic discount
Fair Value
Revenue
15.66% p.a.
Profit Margin
20.77%
Future PE
12.94x
Price in 2029
CA$3.77
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
Expanded Valleyfield Capacity And Blue River Partnership Will Anchor Long-Term Cannabis Upside
Fair Value: CA$4 50.0% undervalued intrinsic discount
4 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Capacity Expansion And Rising SG&A Will Test Margins Yet Future Exports May Offer Relief
Fair Value: CA$3 33.3% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Expanded Capacity And EU Export Optionality Will Support Long Term Premium Cannabis Demand
Fair Value: CA$3.19 37.3% undervalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Cannara Biotech Inc. Key Details
About LOVE
- Founded
- 2017
- Employees
- 452
- CEO
- WebsiteView website
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.
Recent LOVE News & Updates
Analysis Article • Jul 23
Earnings Troubles May Signal Larger Issues for Cannara Biotech (TSE:LOVE) Shareholders
The subdued market reaction suggests that Cannara Biotech Inc.'s ( TSE:LOVE ) recent earnings didn't contain any...
New Narrative • Jul 18
